Thanks Owl,The webinar should be another part of the parcel...

Thanks Owl,

The webinar should be another part of the parcel 'unwrapping', a bit like that party game. We'll see.
They did confirm again yesterday that the first onCARlytic patient was one with ovarian cancer and I think you may
have a professional interest in what they are doing there.

I am hoping that investors will send in quality questions around the science, not just whinges about the SP.
Perhaps the real key or bonus to yesterday's event was that it ran for more than 2 hours, and people like myself
could ask so many questions, in an informal way, because so many of the IMU team were present.

I won't get a chance to watch it live because I will be in 'catch-up mode' - I 'lost' most of yesterday.
I will certain have a look later though.

Good luck to all. As someone said yesterday, in 2024 will have so much news dropping we won't know where to look.

Opinion only, always.